| __timestamp | Ascendis Pharma A/S | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19698000 | 1595000 |
| Thursday, January 1, 2015 | 40528000 | 11434000 |
| Friday, January 1, 2016 | 66022000 | 26546000 |
| Sunday, January 1, 2017 | 99589000 | 39778000 |
| Monday, January 1, 2018 | 140281000 | 53418000 |
| Tuesday, January 1, 2019 | 191621000 | 111997000 |
| Wednesday, January 1, 2020 | 260904000 | 139507000 |
| Friday, January 1, 2021 | 295867000 | 195958000 |
| Saturday, January 1, 2022 | 379624000 | 248149000 |
| Sunday, January 1, 2023 | 413454000 | 232366000 |
| Monday, January 1, 2024 | 307004000 |
Infusing magic into the data realm
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Ascendis Pharma A/S and ImmunityBio, Inc. have been at the forefront of this race since 2014. Over the past decade, Ascendis Pharma has consistently increased its R&D investment, growing by over 2,000% from 2014 to 2023. In contrast, ImmunityBio, Inc. has also shown a significant upward trend, with a nearly 1,500% increase in the same period.
By 2023, Ascendis Pharma's R&D expenses reached approximately 413 million, nearly doubling ImmunityBio's 232 million. This substantial investment underscores Ascendis Pharma's strategic focus on pioneering new treatments. As the biotech industry continues to expand, these companies' R&D commitments highlight their roles as leaders in innovation, shaping the future of healthcare.
R&D Spending Showdown: Alnylam Pharmaceuticals, Inc. vs Ascendis Pharma A/S
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Comparing Innovation Spending: Ascendis Pharma A/S and Mesoblast Limited
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Novavax, Inc.
Research and Development Investment: Ascendis Pharma A/S vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and ImmunityBio, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and ImmunityBio, Inc. Allocate Funds
ImmunityBio, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Mesoblast Limited